Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q4 2024 earnings summary

Executive summary

• Net turnover for 2024 reached €1.7 million, up 7.7% year-over-year, driven by increased genetics industry sales, which made up 75.2% of turnover, while milk analysis services declined to 19.3% of turnover.

• Profit for 2024 was €80.8 thousand, an increase of €15.6 thousand compared to 2023, with no significant impact from the Russia-Ukraine war.

• The company remains the sole producer of high-quality breeding bull semen in Latvia and continues to expand its market and service efficiency.

Financial highlights

• Net sales rose to €1,656,333 in 2024 from €1,537,526 in 2023, with genetics products and services as the main contributor.

• Operating profit before tax was €83,664, up from €68,034 in 2023; net profit after tax was €80,788, up from €65,435.

• Earnings per share increased to €0.191 from €0.155 year-over-year.

• Cash and cash equivalents at year-end were €82,385, down from €154,235 at the end of 2023.

• Shareholders' equity rose to €1,891,603 from €1,831,937, with total assets at €2,268,344.

Outlook and guidance

• Plans to further increase operational efficiency and expand the market for products and services.

• No significant post-balance-sheet events or risks identified that would affect future financial position.